Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline

INTRODUCTION: Intensified chemotherapy improved outcomes for men with poor-prognosis metastatic germ cell cancer (GCC) and unfavorable tumor marker decline after one cycle of bleomycin, etoposide, and cisplatin (BEP) chemotherapy in the GETUG-13 trial. Herein, we report our experience to date using...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can Urol Assoc J
Main Authors: Batra, Anupam, Ernst, Scott, Potvin, Kylea, Fernandes, Ricardo, Power, Nicholas, Vanhie, James, Winquist, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: Canadian Medical Association 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012285/
https://ncbi.nlm.nih.gov/pubmed/31348750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.5802
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados